Cantargia AB Owners | StatInvestor

Health Care & Life Sciences » Biotechnology | Cantargia AB

Cantargia AB | Ownership

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Första AP-fonden

4,550,000

6.88%

4,550,000

0.07%

01/19/2018

Fjärde AP-fonden

2,750,000

4.16%

2,750,000

0.03%

01/19/2018

Andra AP-fonden

2,200,000

3.32%

2,200,000

0.03%

01/19/2018

SEB Investment Management AB

1,998,350

3.02%

1,998,350

0.01%

01/19/2018

Handelsbanken Fonder AB

1,000,000

1.51%

1,000,000

0.02%

01/19/2018

View Profile

Address	Medicon Village Lund SN 223 81 Sweden
Employees	-
Website	http://www.cantargia.com
Updated	09/14/2018
Cantargia AB is a holding company, which engages in the development of antibody-based cancer treatment. It focuses on the development of CAN04 for the treatment of non-small cell lung cancer and pancreatic cancer. The company was founded by Thoas Michael Fioretos, Kjell Torsten Sjostrom, and Marcus Jaras on October 26, 2009 and is headquartered in Lund, Sweden.